Bidirectional relationship between temporomandibular disorder and ankylosing spondylitis: a population-based cohort study.
AS
Ankylosing spondylitis
Bidirectional analysis
Population-based
TMD
Temporomandibular disorder
Journal
Clinical oral investigations
ISSN: 1436-3771
Titre abrégé: Clin Oral Investig
Pays: Germany
ID NLM: 9707115
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
received:
10
01
2021
accepted:
05
04
2021
pubmed:
16
4
2021
medline:
26
10
2021
entrez:
15
4
2021
Statut:
ppublish
Résumé
This study aimed to determine the relation between temporomandibular disorder (TMD) and ankylosing spondylitis (AS) bidirectionally and ascertain the important comorbidities for AS occurrence in TMD patients. We conducted this population-based cohort study through Longitudinal Health Insurance Database, Taiwan. Study 1 investigated the risk of TMD in AS patients. Study 2 assessed the risk of AS in TMD patients. In total, 3204 AS patients and 12,816 age-matched and gender-matched comparisons were enrolled in study 1. The TMD incidence in the AS cohort was 2.88-fold higher when compared with the comparisons (1.54 vs. 0.53 per 10,000 person-years). After adjusting for age, gender, and comorbidity, the AS cohort had a 2.66-fold (95% CI = 1.79-3.97) increased risk of TMD occurrence (P < 0.0001). The second study recruited 4998 TMD patients and 19,991 age-matched and gender-matched comparisons. Both TMD and comparison cohorts showed similar AS risk (HR = 1.49, 95% CI = 0.91-2.43, P = 0.1108) in the adjusted model. Study 2 identified a 3.66-fold increased risk of AS occurrence in TMD patients with comorbidity, including parapsoriasis, rheumatoid arthritis, osteoporosis, Cushing's syndrome, and climacteric arthritis (P < 0.012). AS appears to significantly impact the occurrence of TMD. TMD might play a synergic role in AS development. Clinicians have to be vigilant about the increased risk of TMD in AS patients and take care of AS disease activity and prognosis. The symptoms and signs of TMD could be a predictor of AS in patients with the aforementioned comorbidities.
Identifiants
pubmed: 33855657
doi: 10.1007/s00784-021-03938-0
pii: 10.1007/s00784-021-03938-0
doi:
Types de publication
Journal Article
Langues
eng
Pagination
6377-6384Subventions
Organisme : Ministry of Health and Welfare
ID : MOHW109-TDU-B-212-114004
Organisme : Ministry of Science and Technology, Taiwan
ID : MOST 108-2321-B-039-003
Organisme : Clinical Trial Center, China Medical University Hospital
ID : DMR-109-126
Organisme : Chang Gung Memorial Hospital, Linkou
ID : CMRPG3I0152
Organisme : Far Eastern Memorial Hospital
ID : FEMH-2020-C-030
Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
De Rossi SS, Greenberg MS, Liu F, Steinkeler A (2014) Temporomandibular disorders: Evaluation and management. Med Clin North Am 98:1353–1384. https://doi.org/10.1016/j.mcna.2014.08.009
doi: 10.1016/j.mcna.2014.08.009
pubmed: 25443680
Gynther GW, Holmlund AB, Reinholt FP, Lindblad S (1997) Temporomandibular joint involvement in generalized osteoarthritis and rheumatoid arthritis: A clinical, arthroscopic, histologic, and immunohistochemical study. Int J Oral Maxillofac Surg 26:10–16
doi: 10.1016/S0901-5027(97)80838-7
Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet (London, England) 369:1379–1390. https://doi.org/10.1016/s0140-6736(07)60635-7
doi: 10.1016/s0140-6736(07)60635-7
Resnick D, Niwayama G (1995) Ankylosing spondylitis. In: Resnick D (ed) Diagnosis of bone and joint disorders. WB Saunders, Philadelphia
Kellesarian SV, Al-Kheraif AA, Vohra F, Ghanem A, Malmstrom H, Romanos GE, Javed F (2016) Cytokine profile in the synovial fluid of patients with temporomandibular joint disorders: A systematic review. Cytokine 77:98–106. https://doi.org/10.1016/j.cyto.2015.11.005
doi: 10.1016/j.cyto.2015.11.005
pubmed: 26556103
Taurog JD, Chhabra A, Colbert RA (2016) Ankylosing spondylitis and axial spondyloarthritis. N Engl J Med 374:2563–2574. https://doi.org/10.1056/NEJMra1406182
doi: 10.1056/NEJMra1406182
pubmed: 27355535
Davidson C, Wojtulewski JA, Bacon PA, Winstock D (1975) Temporo-mandibular joint disease in ankylosing spondylitis. Ann Rheum Dis 34:87–91
doi: 10.1136/ard.34.1.87
Wenneberg B, Kononen M, Kallenberg A (1990) Radiographic changes in the temporomandibular joint of patients with rheumatoid arthritis, psoriatic, arthritis, and ankylosing spondylitis. J Craniomandib Disord Facial Oral Pain 4:35–39
Ramos-Remus C, Major P, Gomez-Vargas A, Petrikowski G, Hernandez-Chavez A, Gonzalez-Marin E, Russell AS (1997) Temporomandibular joint osseous morphology in a consecutive sample of ankylosing spondylitis patients. Ann Rheum Dis 56:103–107. https://doi.org/10.1136/ard.56.2.103
doi: 10.1136/ard.56.2.103
pubmed: 9068282
pmcid: 1752329
Helenius LM, Tervahartiala P, Helenius I, Al-Sukhun J, Kivisaari L, Suuronen R, Kautiainen H, Hallikainen D, Lindqvist C, Leirisalo-Repo M (2006) Clinical, radiographic and MRI findings of the temporomandibular joint in patients with different rheumatic diseases. Int J Oral Maxillofac Surg 35:983–989. https://doi.org/10.1016/j.ijom.2006.08.001
doi: 10.1016/j.ijom.2006.08.001
pubmed: 17052893
Aceves-Avila FJ, Chavez-Lopez M, Chavira-Gonzalez JR, Ramos-Remus C (2013) Temporomandibular joint dysfunction in various rheumatic diseases. Reumatismo 65:126–130. https://doi.org/10.4081/reumatismo.2013.126
doi: 10.4081/reumatismo.2013.126
pubmed: 23884028
Bilgin E, Bilgin E, Özdemir O, Kalyoncu U (2020) Temporomandibular disorders in ankylosing spondylitis: A cross-sectional, monocentric study. Rheumatol Int 40:933–940. https://doi.org/10.1007/s00296-020-04563-y
doi: 10.1007/s00296-020-04563-y
pubmed: 32239320
van Hoeven L, Luime J, Han H, Vergouwe Y, Weel A (2014) Identifying axial spondyloarthritis in Dutch primary care patients, ages 20-45 years, with chronic low back pain. Arthritis Care Res 66:446–453. https://doi.org/10.1002/acr.22180
doi: 10.1002/acr.22180
Huang YF, Liu SP, Muo CH, Tsai CH, Chang CT (2020) The association between dental therapy timelines and osteoradionecrosis: A nationwide population-based cohort study. Clin Oral Investig 24:455–463. https://doi.org/10.1007/s00784-019-02866-4
doi: 10.1007/s00784-019-02866-4
pubmed: 31111283
Yildizer Keris E, Yaman SD, Demirag MD, Haznedaroglu S (2017) Temporomandibular joint findings in patients with rheumatoid arthritis, ankylosing spondylitis, and primary Sjogren’s syndrome. J Investig Clin Dent 8. https://doi.org/10.1111/jicd.12255
Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J (2003) Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23:61–66. https://doi.org/10.1007/s00296-002-0237-4
doi: 10.1007/s00296-002-0237-4
pubmed: 12634937
Bodur H, Ataman S, Akbulut L, Evcik D, Kavuncu V, Kaya T, Gunaydin R, Kuran B, Kotevoglu N, Bal A, Aydog E, Altay Z, Ugurlu H, Kocabas H, Olmez N, Yazgan P, Gursoy S, Madenci E, Ozel S, Delialioglu SU (2008) Characteristics and medical management of patients with rheumatoid arthritis and ankylosing spondylitis. Clin Rheumatol 27:1119–1125. https://doi.org/10.1007/s10067-008-0877-1
doi: 10.1007/s10067-008-0877-1
pubmed: 18357499
Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA, Haroon N, Borenstein D, Wang R, Biehl A, Fang MA, Louie G, Majithia V, Ng B, Bigham R, Pianin M, Shah AA, Sullivan N, Turgunbaev M, Oristaglio J, Turner A, Maksymowych WP, Caplan L (2019) 2019 update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheum 71:1599–1613. https://doi.org/10.1002/art.41042
doi: 10.1002/art.41042
Rundback JH, Rosenberg ZS, Solomon G (1993) The radiographic features of rheumatoid arthritis in HLA-B27-positive patients. Skelet Radiol 22:263–267. https://doi.org/10.1007/bf00197671
doi: 10.1007/bf00197671
Jaakkola E, Herzberg I, Laiho K, Barnardo MCNM, Pointon JJ, Kauppi M, Kaarela K, Tuomilehto-Wolf E, Tuomilehto J, Wordsworth BP, Brown MA (2006) Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis. Ann Rheum Dis 65:775–780. https://doi.org/10.1136/ard.2005.041103
doi: 10.1136/ard.2005.041103
pubmed: 16249228
Magrey M, Khan MA (2010) Osteoporosis in ankylosing spondylitis. Curr Rheumatol Rep 12:332–336. https://doi.org/10.1007/s11926-010-0122-1
doi: 10.1007/s11926-010-0122-1
pubmed: 20680529
Li T, Liu WB, Tian FF, Jiang JJ, Wang Q, Hu FQ, Hu WH, Zhang XS (2020) Gender-specific SBNO2 and VPS13B as a potential driver of osteoporosis development in male ankylosing spondylitis. Osteoporos Int 32:311–320. https://doi.org/10.1007/s00198-020-05593-9
doi: 10.1007/s00198-020-05593-9
pubmed: 32803317
Dervis E (2005) Oral implications of osteoporosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100:349–356. https://doi.org/10.1016/j.tripleo.2005.04.010
doi: 10.1016/j.tripleo.2005.04.010
pubmed: 16122665
Dumbuya A, Gomes AF, Marchini L, Zeng E, Comnick CL, Melo SLS (2020) Bone changes in the temporomandibular joints of older adults: A cone-beam computed tomography study. Spec Care Dentist 40:84–89. https://doi.org/10.1111/scd.12441
doi: 10.1111/scd.12441
pubmed: 31799710
Manishkina RP, Andrusenko AB, Donskov SI, Kalinin AP, Klinova EG (1984) The HLA system and Itsenko-Cushing disease. Ter Arkh 56:133–135
pubmed: 6333733
Davydova IV, Andrusenko AB (1990) The role of glucocorticoid receptors and HLA antigens in the pathogenesis of Cushing’s syndrome. Klin Med (Mosk) 68:115–119
Huang YF, Liu SP, Muo CH, Chang CT, Tsai CH, Morisky DE (2019) Sialadenitis may be associated with an increased risk for osteoradionecrosis: A nationwide population-based cohort study. J Oral Maxillofac Surg 77:1392–1400. https://doi.org/10.1016/j.joms.2019.01.047
doi: 10.1016/j.joms.2019.01.047
pubmed: 30826391